The Chemiluminescence Immunoassay Analyzer (CLIA) is a high-performance in-vitro diagnostic system designed for quantitative detection of biological markers in human serum, plasma, urine, and other samples.
It is widely used in modern clinical laboratories for high-sensitivity testing of hormones, tumor markers, infectious diseases, cardiac markers, and autoimmune diseases.
The system is based on chemiluminescent microparticle immunoassay (CMIA) technology, providing high accuracy, strong specificity, and low detection limits.
CLIA technology provides ultra-sensitive detection of trace biomarkers, making it suitable for early disease screening and precise diagnosis.
From sample loading to result output, the system minimizes manual intervention, reducing human error and improving laboratory efficiency.
Supports batch and continuous testing mode, enabling laboratories to process multiple samples efficiently, ideal for medium to large hospital labs.
The system supports a broad range of clinical assays including:
Advanced magnetic particle separation and chemiluminescent detection ensure stable reaction performance and reproducible results.
Supports multiple biological samples:
The CLIA analyzer is widely used in:
| Item | Specification |
|---|---|
| Technology | Chemiluminescent Microparticle Immunoassay (CMIA) |
| System Type | Fully automated immunoassay analyzer |
| Sample Mode | Batch / Random access |
| Sample Types | Serum / Plasma / Urine |
| Throughput | High-throughput (model dependent) |
| Reaction Principle | Antigen-antibody chemiluminescence reaction |
| Detection Method | Photomultiplier-based optical detection |
| Interface | LIS/HIS connectivity supported |
| Calibration | Automatic calibration system |
| QC System | Multi-level quality control support |
no comments